Code | 93174 | ||||||||||
MA number | 16/0226/13-S | ||||||||||
Product Form: | plv iio 1x1000 IU+20 ml solv.(liek.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Baxalta Innovations GmbH, Austria | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 12.04.1989 |
Pediatric warnings: | Yes |
SPC: | SPC_Antithrombin III Baxalta 1000 IU_12.2020.doc |
PIL: | PIL_ANTITHROMBIN III BAXALTA 500 IU_1000 IU_05.2022.pdf |
Safety feature | Yes |
Data update: | 21.12.2018 |